Drug recall · November 10, 2021
Dr. Reddy's Ezetimibe and Simvastatin Tablets recall
Why: Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 count (NDC 43598-745-30), b) 90 count (NDC 43598-745-90), and c) 500 count (NDC 43598-745-05) bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA
- Lots / codes
a) L100160, exp 01/2023 b) L100249, exp 01/2023 c) L100250, exp 01/2023
- Quantity
- a) 3,444 bottles b) 469 bottles c) 142 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Distribution
- Nationwide in the US
- Initiated
- October 5, 2021 · Voluntary: Firm initiated
- Classified
- October 29, 2021
- Reported
- November 10, 2021
- Ended
- February 16, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ezetimibe / simvastatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.